GSK announces $30 billion investment in US R&D and manufacturing
PositiveFinancial Markets

GSK has announced a significant $30 billion investment in research and development as well as manufacturing in the United States. This move is expected to bolster the country's healthcare sector, create jobs, and enhance innovation in pharmaceuticals. By committing such a substantial amount, GSK aims to strengthen its presence in the US market and contribute to advancements in medical science, which is crucial for addressing public health challenges.
— Curated by the World Pulse Now AI Editorial System